阿普斯特成功治疗麻风结节性红斑。 - Suppr

Suppr

超能文献

Successful treatment of erythema nodosum leprosum with apremilast.

作者信息

Abril-Pérez Carlos, Palacios-Diaz Rodolfo David, Navarro-Mira Miguel Ángel, Botella-Estrada Rafael

机构信息

Dermatology Department, Hospital Universitario y Politécnico La Fe, Valencia, Spain.

Dermatology, Universitat de València, Valencia, Spain.

出版信息

Dermatol Ther. 2022 Mar;35(3):e15258. doi: 10.1111/dth.15258. Epub 2021 Dec 15.

DOI:10.1111/dth.15258

PMID:34890096

Abstract

摘要

相似文献

Successful treatment of erythema nodosum leprosum with apremilast.

Dermatol Ther. 2022 Mar;35(3):e15258. doi: 10.1111/dth.15258. Epub 2021 Dec 15.

Effective management of severe chronic erythema nodosum leprosum in adolescent patient using ustekinumab and apremilast: A case report.

J Eur Acad Dermatol Venereol. 2024 Mar;38(3):e244-e246. doi: 10.1111/jdv.19552. Epub 2023 Oct 18.

Asymmetrical ocular affliction in a case of recurrent erythema nodosum leprosum-an uncommon manifestation of leprosy in contemporary times.

Int J Dermatol. 2022 Nov;61(11):e441-e443. doi: 10.1111/ijd.16195. Epub 2022 Apr 11.

Erythema nodosum leprosum successfully treated with apremilast: more effective and safer than classic treatments?

Int J Dermatol. 2021 Feb;60(2):e74-e76. doi: 10.1111/ijd.15205. Epub 2020 Sep 24.

Histoid leprosy complicated by erythema nodosum leprosum mimicking connective tissue disease.

Trop Doct. 2023 Oct;53(4):533-535. doi: 10.1177/00494755231185987. Epub 2023 Jul 4.

Apremilast in multibacillary leprosy patients with chronic and recurrent erythema nodosum leprosum: a prospective single-centre pilot study.

J Eur Acad Dermatol Venereol. 2021 Dec;35(12):e917-e919. doi: 10.1111/jdv.17585. Epub 2021 Sep 2.

Recurrent erythema nodosum leprosum leading to secondary renal amyloidosis and nephrotic syndrome in an Indian patient with lepromatous leprosy.

Int J Dermatol. 2023 Sep;62(9):e514-e517. doi: 10.1111/ijd.16693. Epub 2023 Apr 17.

Chronic recalcitrant erythema nodosum leprosum: therapeutic dilemma and role of mycobacterium indicus pranii vaccine.

An Bras Dermatol. 2022 Jan-Feb;97(1):49-53. doi: 10.1016/j.abd.2020.08.032. Epub 2021 Nov 27.

Apremilast in chronic recalcitrant erythema nodosum leprosum: a report of two cases.

Br J Dermatol. 2020 Apr;182(4):1034-1037. doi: 10.1111/bjd.18233. Epub 2019 Sep 5.

Atypical presentations of erythema nodosum leprosum: Diagnostic and therapeutic aspects.

J Dtsch Dermatol Ges. 2021 Aug;19(8):1133-1143. doi: 10.1111/ddg.14449. Epub 2021 May 25.

引用本文的文献

Exploring the Therapeutic Landscape: A Narrative Review on Topical and Oral Phosphodiesterase-4 Inhibitors in Dermatology.

Pharmaceutics. 2025 Jan 12;17(1):91. doi: 10.3390/pharmaceutics17010091.

Methotrexate as a corticosteroid-sparing agent in leprosy reactions: A French multicenter retrospective study.

PLoS Negl Trop Dis. 2023 Apr 20;17(4):e0011238. doi: 10.1371/journal.pntd.0011238. eCollection 2023 Apr.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Successful treatment of erythema nodosum leprosum with apremilast.

作者信息

Abril-Pérez Carlos, Palacios-Diaz Rodolfo David, Navarro-Mira Miguel Ángel, Botella-Estrada Rafael

机构信息

Dermatology Department, Hospital Universitario y Politécnico La Fe, Valencia, Spain.

Dermatology, Universitat de València, Valencia, Spain.

出版信息

Dermatol Ther. 2022 Mar;35(3):e15258. doi: 10.1111/dth.15258. Epub 2021 Dec 15.

DOI:10.1111/dth.15258

PMID:34890096

Abstract

摘要

相似文献

Successful treatment of erythema nodosum leprosum with apremilast.

Dermatol Ther. 2022 Mar;35(3):e15258. doi: 10.1111/dth.15258. Epub 2021 Dec 15.

Effective management of severe chronic erythema nodosum leprosum in adolescent patient using ustekinumab and apremilast: A case report.

J Eur Acad Dermatol Venereol. 2024 Mar;38(3):e244-e246. doi: 10.1111/jdv.19552. Epub 2023 Oct 18.

Asymmetrical ocular affliction in a case of recurrent erythema nodosum leprosum-an uncommon manifestation of leprosy in contemporary times.

Int J Dermatol. 2022 Nov;61(11):e441-e443. doi: 10.1111/ijd.16195. Epub 2022 Apr 11.

Erythema nodosum leprosum successfully treated with apremilast: more effective and safer than classic treatments?

Int J Dermatol. 2021 Feb;60(2):e74-e76. doi: 10.1111/ijd.15205. Epub 2020 Sep 24.

Histoid leprosy complicated by erythema nodosum leprosum mimicking connective tissue disease.

Trop Doct. 2023 Oct;53(4):533-535. doi: 10.1177/00494755231185987. Epub 2023 Jul 4.

Apremilast in multibacillary leprosy patients with chronic and recurrent erythema nodosum leprosum: a prospective single-centre pilot study.

J Eur Acad Dermatol Venereol. 2021 Dec;35(12):e917-e919. doi: 10.1111/jdv.17585. Epub 2021 Sep 2.

Recurrent erythema nodosum leprosum leading to secondary renal amyloidosis and nephrotic syndrome in an Indian patient with lepromatous leprosy.

Int J Dermatol. 2023 Sep;62(9):e514-e517. doi: 10.1111/ijd.16693. Epub 2023 Apr 17.

Chronic recalcitrant erythema nodosum leprosum: therapeutic dilemma and role of mycobacterium indicus pranii vaccine.

An Bras Dermatol. 2022 Jan-Feb;97(1):49-53. doi: 10.1016/j.abd.2020.08.032. Epub 2021 Nov 27.

Apremilast in chronic recalcitrant erythema nodosum leprosum: a report of two cases.

Br J Dermatol. 2020 Apr;182(4):1034-1037. doi: 10.1111/bjd.18233. Epub 2019 Sep 5.

Atypical presentations of erythema nodosum leprosum: Diagnostic and therapeutic aspects.

J Dtsch Dermatol Ges. 2021 Aug;19(8):1133-1143. doi: 10.1111/ddg.14449. Epub 2021 May 25.

引用本文的文献

Exploring the Therapeutic Landscape: A Narrative Review on Topical and Oral Phosphodiesterase-4 Inhibitors in Dermatology.

Pharmaceutics. 2025 Jan 12;17(1):91. doi: 10.3390/pharmaceutics17010091.

Methotrexate as a corticosteroid-sparing agent in leprosy reactions: A French multicenter retrospective study.

PLoS Negl Trop Dis. 2023 Apr 20;17(4):e0011238. doi: 10.1371/journal.pntd.0011238. eCollection 2023 Apr.